| COVID-19 |
1 |
1 |
| Vaccines |
0 |
0.86 |
| T-Lymphocyte |
0 |
0.76 |
| HIV Infection |
0 |
0.58 |
| Immunization |
0 |
0.38 |
| Otolaryngology |
0 |
0.34 |
| Pandemic |
0 |
0.25 |
| Upper Respiratory Tract Infection |
0 |
0.18 |
| California |
0 |
0.13 |
| Child |
0 |
0.13 |
| Immunocompromise |
0 |
0.13 |
| Immunoglobulin A (IgA) |
0 |
0.13 |
| Immunoglobulin G (IgG) |
0 |
0.13 |
| International Practice of Medicine |
0 |
0.13 |
| Memory |
0 |
0.13 |
| Mouth |
0 |
0.13 |
| Nasal Mucosa |
0 |
0.13 |
| Nose |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| Respiratory Tract Infections |
0 |
0.13 |
| Revenue and Practice Management |
0 |
0.09 |